Ankyra Therapeutics
Ankyra Therapeutics is a clinical-stage biotechnology company based in Cambridge, Massachusetts, developing "anchored" immunotherapies for cancer and immune-mediated diseases. Its proprietary platform tethers immune-modulating drugs to aluminum hydroxide so that treatment concentrates locally at the disease site, broadening the therapeutic window while reducing systemic toxicity and dosing frequency. The lead candidate, ANK-101, is an anchored IL-12 therapy in clinical evaluation for patients with advanced solid tumors. Ankyra is backed by investors including Google Ventures (GV), Mithril, Polaris Partners, Sands Capital, and Fidelity. The company publishes no public developer API, SDK, or technical platform; this profile exists in the API Evangelist network for discovery and enrichment.
Index entry only — little beyond a description and a link, and nothing machine-readable enough for an agent to act on without a human reading the site first.
API Evangelist profiles Ankyra Therapeutics the way a machine reads it — 1 machine-readable artifact, pulled from the provider's own public surface and indexed so a developer, an analyst, or an AI agent can evaluate it against every other provider on the network.
Every provider in the network is reduced to the same set of machine-readable artifacts — OpenAPI contracts, event specifications, GraphQL schemas, runnable collections, pricing and rate-limit signals, security posture, OAuth scopes, and the agent surfaces (MCP servers and skills) that let software drive the API on its own. We profile them because the interface is the part of a company you can actually inspect: it is a truer signal of what a provider does than any marketing page. From those artifacts we compute the Kin Score — Ankyra Therapeutics scores 8.1/100 (minimal), with a separate agent-readiness read of 0/100 (human only). The full breakdown is below, followed by every artifact we hold — each card links through to its machine-readable definition on apis.io.
Kin Score
This is the API Evangelist rating — a single, repeatable read computed from the artifacts on this page. Green fill is points earned; the red track is points possible, so every bar shows earned-versus-possible at a glance.
Kin Score
How this is scored →scored 2026-07-27 · rubric v0.5
How we profile Ankyra Therapeutics
Each block below is one kind of artifact we hold for Ankyra Therapeutics. For each we say what it is and why it earns a place in the profile, then list every one we've indexed — capped at two rows, scroll within the panel for the rest.
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals — the evidence that a provider takes security seriously enough to document it. We profile it because you can't govern what you can't see.
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Every other property we hold for Ankyra Therapeutics — documentation, portals, status pages, policies, and corporate surface — grouped by the job it does, following the integrator's arc from getting started to running in production.
Agent Surfaces 1
MCP servers, agent skills, and machine-readable catalogs
Access & Security 1
Authentication, authorization, and security posture
Company 5
The organization behind the API
← All providers · Data indexed from github.com/api-evangelist/ankyra-therapeutics · machine-readable index on apis.io